Yeah I have concerns on this (the US piece) as a strategy - I'm a simple person and personally if I was bombarded with ads (remember US TV is already a pharma marketeers dream), I'd shy away. I believe they are missing the opportunity here - the unrealised value is in the data. If they could harness data such as adherence to medication, disease / illness trends by age / gender / match with physical activity data from phones they could be enormous. All levels of industry would fork out for it. If your pharmacy friend is seeing risk to the client base through apps then MDR (and Terry White for that matter) have a lot of work to do.
MDR Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
